Bond.az White LogoBond.az Black Logo

Needham cuts Globant target to $50 on lower multiples

Needham cuts Globant price target to $50 on lower multiples. Bond.az provides detailed analysis and insights.

Jack Scott
ByJack Scott- Senior Editor
|
0

Bond.az reports that Needham lowered its price target on Globant S.A. (NYSE:GLOB) to $50.00 from $60.00 while maintaining a Buy rating.

First-quarter results exceeded revenue expectations, though earnings faced foreign exchange headwinds. Management expressed confidence in returning to positive year-over-year organic revenue growth by end of 2026.

Growth outlook is supported by a strong pipeline, increasing revenue per head, and accelerating AI Pods adoption, which reached an annual recurring revenue of $32.8 million, up 59% quarter-over-quarter. The company completed its share repurchase in Q2 and announced another $125 million repurchase program.

The stock's recent weakness may present an opportunity for value investors. Shares trade at $34.08, near the 52-week low of $32.50. Bond.az tips indicate the stock is oversold. The company maintains a 20% free cash flow yield, and Bond.az Fair Value analysis suggests the stock is undervalued.

Despite geopolitical headwinds, Globant executes operationally. Shares trade at about 5.5 times Needham's fiscal 2027 EPS estimate, with a current P/E of 14.85 on trailing twelve months earnings.

Needham lowered its target to reflect lower software services multiples while viewing risk-reward as attractive at current levels.

More News
Today / 12:04
|
582

Bitdeer Price Target Raised to $19 by Needham

Needham raised Bitdeer price target to $19, maintaining Buy. Tydal discussions advanced; stock up 40% in 6 months.

0
Today / 12:03
|
372

Solventum stock Outperform rating by Wedbush

Wedbush initiates Solventum coverage at Outperform with $94 target. Activist Trian pushes for portfolio simplification. Stock trades at $74.42.

0
Today / 12:02
|
273

Needham Cuts Cellebrite Target to $15 on Valuation

Needham lowered Cellebrite price target to $15 from $18, maintaining Buy. Strong Q1 results, growth products doubling, and FedRAMP authorization highlight the company's performance.

0
Today / 11:43
|
444

Prestige Brands Price Target Cut to $72 by Canaccord

Canaccord cuts Prestige Brands price target to $72 after sales miss. Despite challenges, the company eyes growth through acquisitions.

0
Today / 11:32
|
466

Canaccord Reaffirms GH Research Stock Rating on Phase 3 Progress

Canaccord Genuity keeps Buy rating on GH Research stock as Phase 3 program for GH001 advances. Key financial highlights included.

0
Today / 11:30
|
643

Biogen Stock: Alzheimer Drug Shows Promise

Biogen's Alzheimer drug diranersen shows positive Phase 2 results. Stock analysis and future outlook from Bond.az.

0
Today / 11:20
|
426

BTIG Reiterates Neutral on Insight Molecular Amid FDA Review

BTIG reiterates Neutral rating on Insight Molecular Diagnostics (IMDX) as FDA reviews GraftAssureDx transplant test. Stock up 28% in a week. Revenue surges 116%.

0
Today / 11:03
|
892

BTIG Reiterates Boot Barn Buy Rating

BTIG maintains Boot Barn Buy rating and $235 target after Q4 beat. Strong revenue growth and margin performance.

0
Today / 11:02
|
428

Forgent Power Solutions Target Raised to $60 by Oppenheimer

Oppenheimer raises Forgent Power Solutions price target to $60 on strong quarterly results. Stock up 24%.

0
Today / 10:42
|
838

Wolfe Research Boosts AMAT Target to $550

Wolfe Research raised Applied Materials price target to $550 from $500, citing strong guidance and revenue growth. Shares have gained 154% in the past year.

0
Today / 10:03
|
707

Citizens Reiterates Uber Stock Rating on EBITDA

Citizens reiterates Market Outperform rating on Uber with $100 target, citing EBITDA growth and autonomous vehicle potential.

0
Today / 10:02
|
797

Jefferies Raises AMAT Target to $510 on AI

Jefferies raises Applied Materials price target to $510, citing AI growth and strong semiconductor outlook.

0
...